Our Team

We’ve brought together commercial leaders, researchers and biotechnology experts that will transform therapeutics development.

AmacaThera is a clinical-stage biotechnology company developing a novel drug delivery platform to improve patient outcomes across multiple therapeutic areas, including:

  • post-surgical pain management
  • cancer
  • other hard-to-reach targets

We’re developing products at the intersection of bio­ma­te­ri­als and pharmaceuticals.

Molecule yellow

Senior Management Team

Dr Mike Cooke v2
Dr. Mike Cooke
Co-Founder & CEO
PhD
Biomedical Engineer
Polymer design and drug delivery expert
Dr Molly Shoichet v2
Dr. Molly Shoichet
Co-Founder & Chief Science Officer
PhD
Chemical & Biomedical Engineer
Polymer design and drug delivery expert
Mike Foorer v2
Mike Foorer
Vice President Business Development & General Manager
25 years experience in drug delivery & sterile injectable manufacturing

Board of Directors

In addition to co-founders Mike Cooke and Molly Shoichet, our board is made up of the following:

Lu han
Lu Han
Principal, Lumira Ventures
BSc, PhD
Michelle Scarborough v1
Michelle Scarborough
Managing Partner,
Strategic Investments and Women in Technology Fund, BDC
PhD
Sara Secall v1
Sara Secall
Partner & Life Sciences Investment Director, Inveready Asset Management
Mike Serrano Wu v1
Mike Serrano-Wu
Partner, Sprout BioVentures
PhD

Recent News

Press Release

AmacaThera CEO Mike Cooke accepted to adMare BioInnovations 2021-22 Executive Institute

adMare BioInnovations is pleased to announce the nine women and nine men from diverse backgrounds and representing a wide range of life science businesses across the country, selected to join this year’s adMare Academy Executive Institute.Read more

Top20 Amaca Thera FB
Press Release

AmacaThera named CIX Top 20 Early company

Amacathera Inc. has been named a Canadian Innovation Exchange (CIX)’s Top 20 Early company for 2021.Read more

Media Coverage

CBC's Quirks & Quarks features AmacaThera Co-Founder Dr. Molly Shoichet

ICYMI: Thanks to CBC's Quirks and Quarks for re-running this November 2020 interview with our co-founder, Dr. Molly Shoichet.Read more